Skip to content

Clinical trials

Phase 4 Bone Diseases, Metabolic trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Bone Diseases, Metabolic Phase: Phase 4 Country / region: Canada Clear all

6 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20121
20151
20181

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca1
Eli Lilly and Company1
Jewish General Hospital1
McMaster University1
Saskatchewan Health Authority - Regina Area1
University of Alberta1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Bone Diseases, Metabolic6
Osteoporosis2
Acquired Immunodeficiency Syndrome1
Breast Neoplasms1
Coinfection1
Crohn Disease1
Cystic Fibrosis1
Hepatitis C1
Hepatitis C, Chronic1
Inflammatory Bowel Diseases1

Trials

Showing 1 to 6 of 6. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.